A signature of circulating miRNAs predicts the prognosis and therapeutic outcome of taxane/platinum regimen in advanced ovarian carcinoma patients

R Pal, T Choudhury, M Ghosh, M Vernakar… - Clinical and …, 2024 - Springer
Purpose Ovarian carcinoma (OC) is ranked as the eighth most lethal gynecological cancer
due to late diagnosis and high recurrence. Existing biomarkers are lacking to predict the …

miR-203 is an independent molecular predictor of prognosis and treatment outcome in ovarian cancer: a multi-institutional study

K Panoutsopoulou, M Avgeris, K Mavridis… - …, 2020 - academic.oup.com
Ovarian cancer (OC) accounts for the most gynecological cancer-related deaths in
developed countries. Unfortunately, the lack of both evident early symptoms and effective …

Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer

A Mahdian-Shakib, R Dorostkar, M Tat… - Biomedicine & …, 2016 - Elsevier
Ovarian cancer (OC) is the most lethal of malignant gynecological cancers, and has a very
poor prognosis, frequently, attributable to late diagnosis and responsiveness to …

Transcriptomic analysis reveals tumor stage-or grade-dependent expression of miRNAs in serous ovarian cancer

C Berkel, E Cacan - Human Cell, 2021 - Springer
Ovarian cancer (OC) is the most lethal gynecological malignancy and cellular mechanisms
regulating OC progression are not completely understood. miRNAs are involved in many …

[HTML][HTML] Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer

H Zheng, L Zhang, Y Zhao, D Yang, F Song, Y Wen… - PloS one, 2013 - journals.plos.org
Background Most (70%) epithelial ovarian cancers (EOCs) are diagnosed late. Non-invasive
biomarkers that facilitate disease detection and predict outcome are needed. The …

Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis

SO Ebrahimi, S Reiisi - Archives of gynecology and obstetrics, 2019 - Springer
Background and purpose Ovarian cancer (OC) is one of the most fatal malignancies in
women. High mortality rate may be due to problems with diagnosis in the early stages. The …

[HTML][HTML] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer

MK Pal, SP Jaiswar, VN Dwivedi… - Cancer biology & …, 2015 - ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
malignancies. Despite the technological and medical advances over the past four decades …

Serum miR-1181 and miR-4314 associated with ovarian cancer: MiRNA microarray data analysis for a pilot study

L Ruan, Y Xie, F Liu, X Chen - … Journal of Obstetrics & Gynecology and …, 2018 - Elsevier
Objective This study aims to identify serum microRNAs (miRNAs) related to ovarian cancer.
Study design MiRNA profiling data (GSE79943) were generated from the Gene Expression …

[HTML][HTML] MiR-494 inhibits epithelial ovarian cancer growth by targeting c-Myc

J Yuan, K Wang, M Xi - Medical science monitor: international …, 2016 - ncbi.nlm.nih.gov
MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc - PMC Back to Top Skip
to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main …

[HTML][HTML] Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer

B Dogan, E Gumusoglu, E Ulgen… - Genomics & …, 2022 - ncbi.nlm.nih.gov
Recent studies have focused on the early detection of ovarian cancer (OC) using tumor
materials by liquid biopsy. The mechanisms of microRNAs (miRNAs) to impact OC and …